TreeWAS – Variant ID: rs1520339

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H02.4 Ptosis of eyelid	0.045	0.955	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.971	0.029
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.972	0.028
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.972	0.028
F45.8 Other somatoform disorders	0.028	0.972	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.972	0.028
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.972	0.028
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.974	0.026
T36 Poisoning by systemic antibiotics	0.000	0.976	0.024
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.976	0.024
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.976	0.024
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.977	0.023
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.978	0.022
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.978	0.022
T38.1 Thyroid hormones and substitutes	0.000	0.978	0.022
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.978	0.022
T43.6 Psychostimulants with abuse potential	0.000	0.978	0.022
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.979	0.021
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.979	0.021
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.979	0.021
T36.0 Penicillins	0.000	0.979	0.021
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.979	0.021
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.979	0.021
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.979	0.021
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.979	0.021
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.979	0.021
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.979	0.020
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.979	0.020
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.979	0.020
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.979	0.020
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.979	0.020
T44.0 Anticholinesterase agents	0.000	0.979	0.020
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.980	0.020
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.980	0.020
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.980	0.020
T43.9 Psychotropic drug, unspecified	0.000	0.980	0.020
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.980	0.020
T38.0 Glucocorticoids and synthetic analogues	0.000	0.980	0.020
T38.5 Other oestrogens and progestogens	0.000	0.980	0.019
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.981	0.019
T36.3 Macrolides	0.000	0.981	0.019
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.019	0.981	0.000
T46.1 Calcium-channel blockers	0.000	0.981	0.019
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.981	0.019
T47.6 Antidiarrhoeal drugs	0.000	0.981	0.019
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.981	0.019
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.981	0.019
T38.9 Other and unspecified hormone antagonists	0.000	0.981	0.019
T38.7 Androgens and anabolic congeners	0.000	0.981	0.019
T38.4 Oral contraceptives	0.000	0.981	0.019
T38.2 Antithyroid drugs	0.000	0.981	0.019
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.981	0.019
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.981	0.019
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.981	0.018
T47.0 Histamine H(2)-receptor antagonists	0.000	0.982	0.018
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.982	0.018
T50.4 Drugs affecting uric acid metabolism	0.000	0.982	0.018
T36.9 Systemic antibiotic, unspecified	0.000	0.982	0.017
T36.7 Antifungal antibiotics, systemically used	0.000	0.982	0.017
T36.6 Rifamycins	0.000	0.982	0.017
T36.5 Aminoglycosides	0.000	0.982	0.017
T36.2 Chloramphenicol group	0.000	0.982	0.017
T47.2 Stimulant laxatives	0.000	0.982	0.017
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.982	0.017
T36.8 Other systemic antibiotics	0.000	0.983	0.017
T39.4 Antirheumatics, not elsewhere classified	0.000	0.983	0.017
T39.2 Pyrazolone derivatives	0.000	0.983	0.017
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.983	0.017
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.983	0.017
T47.7 Emetics	0.000	0.983	0.017
T47.5 Digestants	0.000	0.983	0.017
T47.3 Saline and osmotic laxatives	0.000	0.983	0.017
T42.1 Iminostilbenes	0.000	0.983	0.017
T36.4 Tetracyclines	0.000	0.983	0.017
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.983	0.017
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.983	0.017
T42.2 Succinimides and oxazolidinediones	0.000	0.983	0.017
T43.2 Other and unspecified antidepressants	0.000	0.983	0.017
T45.5 Anticoagulants	0.000	0.983	0.017
T92.9 Sequelae of unspecified injury of upper limb	0.017	0.983	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.984	0.016
T42.3 Barbiturates	0.000	0.984	0.016
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.984	0.016
F45 Somatoform disorders	0.016	0.984	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.984	0.016
T50.7 Analeptics and opioid receptor antagonists	0.000	0.984	0.016
T50.5 Appetite depressants	0.000	0.984	0.016
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.984	0.016
T50.0 Mineralocorticoids and their antagonists	0.000	0.984	0.016
T45.0 Antiallergic and antiemetic drugs	0.000	0.984	0.016
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.984	0.016
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.984	0.016
T45.8 Other primarily systemic and haematological agents	0.000	0.984	0.016
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.984	0.016
T45.6 Fibrinolysis-affecting drugs	0.000	0.984	0.016
T45.4 Iron and its compounds	0.000	0.984	0.016
T45.3 Enzymes, not elsewhere classified	0.000	0.984	0.016
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.984	0.015
T42.0 Hydantoin derivatives	0.000	0.984	0.015
T47.4 Other laxatives	0.000	0.985	0.015
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.985	0.015
T49.9 Topical agent, unspecified	0.000	0.985	0.015
T49.8 Other topical agents	0.000	0.985	0.015
T49.7 Dental drugs, topically applied	0.000	0.985	0.015
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.985	0.015
T49.5 Ophthalmological drugs and preparations	0.000	0.985	0.015
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.985	0.015
T49.3 Emollients, demulcents and protectants	0.000	0.985	0.015
T49.2 Local astringents and local detergents	0.000	0.985	0.015
T49.1 Antipruritics	0.000	0.985	0.015
T41.5 Therapeutic gases	0.000	0.985	0.015
T41.4 Anaesthetic, unspecified	0.000	0.985	0.015
T41.3 Local anaesthetics	0.000	0.985	0.015
T41.2 Other and unspecified general anaesthetics	0.000	0.985	0.015
T41.1 Intravenous anaesthetics	0.000	0.985	0.015
T41.0 Inhaled anaesthetics	0.000	0.985	0.015
H25.9 Senile cataract, unspecified	0.000	0.985	0.015
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.985	0.015
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.985	0.015
T46.7 Peripheral vasodilators	0.000	0.985	0.015
T50.8 Diagnostic agents	0.000	0.985	0.015
T50.1 Loop [high-ceiling] diuretics	0.000	0.985	0.015
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.985	0.015
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.985	0.014
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.986	0.014
T48.4 Expectorants	0.000	0.986	0.014
T48.3 Antitussives	0.000	0.986	0.014
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.986	0.014
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.986	0.014
T48.0 Oxytocic drugs	0.000	0.986	0.014
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.986	0.014
T45.2 Vitamins, not elsewhere classified	0.000	0.986	0.014
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.986	0.014
T39.1 4-Aminophenol derivatives	0.000	0.986	0.014
F45.3 Somatoform autonomic dysfunction	0.014	0.986	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.986	0.014
T37.5 Antiviral drugs	0.000	0.986	0.014
T37.4 Anthelminthics	0.000	0.986	0.014
T37.3 Other antiprotozoal drugs	0.000	0.986	0.014
T37.1 Antimycobacterial drugs	0.000	0.986	0.014
T37.0 Sulphonamides	0.000	0.986	0.014
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.986	0.013
T48.5 Anti-common-cold drugs	0.000	0.986	0.013
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.987	0.013
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.987	0.013
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.987	0.013
T39.0 Salicylates	0.000	0.987	0.013
T40.2 Other opioids	0.000	0.987	0.013
T40.6 Other and unspecified narcotics	0.000	0.987	0.013
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.988	0.012
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.988	0.012
F45.4 Persistent somatoform pain disorder	0.012	0.988	0.000
F45.2 Hypochondriacal disorder	0.012	0.988	0.000
F45.9 Somatoform disorder, unspecified	0.012	0.988	0.000
T40.1 Heroin	0.000	0.988	0.012
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.988	0.012
T40.8 Lysergide [LSD]	0.000	0.988	0.012
T40.7 Cannabis (derivatives)	0.000	0.988	0.012
T40.0 Opium	0.000	0.988	0.012
F45.1 Undifferentiated somatoform disorder	0.012	0.988	0.000
T40.3 Methadone	0.000	0.989	0.011
T40.5 Cocaine	0.000	0.989	0.011
K50.0 Crohn's disease of small intestine	0.011	0.989	0.000
F45.0 Somatisation disorder	0.010	0.990	0.000
T42.4 Benzodiazepines	0.000	0.990	0.010
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.010	0.990	0.000
K50.1 Crohn's disease of large intestine	0.009	0.991	0.000
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.009	0.991	0.000
K50 Crohn's disease [regional enteritis]	0.009	0.991	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.009	0.991	0.000
K50.9 Crohn's disease, unspecified	0.008	0.992	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.008	0.992	0.000
N18.0 End-stage renal disease	0.007	0.993	0.000
R06.5 Mouth breathing	0.007	0.993	0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.007	0.993	0.000
T92 Sequelae of injuries of upper limb	0.007	0.993	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.007	0.993	0.000
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.007	0.993	0.000
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.007	0.993	0.000
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
T40.4 Other synthetic narcotics	0.000	0.994	0.006
E87.5 Hyperkalaemia	0.006	0.994	0.000
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
T92.0 Sequelae of open wound of upper limb	0.006	0.994	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
T92.4 Sequelae of injury of nerve of upper limb	0.006	0.994	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.005	0.995	0.000
Q05.9 Spina bifida, unspecified	0.005	0.995	0.000
X63.0 Home	0.000	0.995	0.005
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.005	0.995	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.005	0.995	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.005	0.995	0.000
O94-O99 Other obstetric conditions, not elsewhere classified	0.004	0.995	0.000
N60.1 Diffuse cystic mastopathy	0.004	0.996	0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.004	0.996	0.000
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.000	0.996	0.004
L05.9 Pilonidal cyst without abscess	0.000	0.996	0.004
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.000	0.996	0.004
M84.1 Nonunion of fracture [pseudarthrosis]	0.004	0.996	0.000
T92.1 Sequelae of fracture of arm	0.004	0.996	0.000
M10.96 Gout, unspecified (Lower leg)	0.004	0.996	0.000
N91.2 Amenorrhoea, unspecified	0.004	0.996	0.000
Q05 Spina bifida	0.004	0.996	0.000
K75.0 Abscess of liver	0.000	0.996	0.004
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.004	0.996	0.000
H80.9 Otosclerosis, unspecified	0.004	0.996	0.000
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.003	0.996	0.000
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.004	0.996	0.000
O97 Death from sequelae of direct obstetric causes	0.003	0.996	0.000
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.003	0.996	0.000
O95 Obstetric death of unspecified cause	0.003	0.996	0.000
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.003	0.996	0.000
Q05.7 Lumbar spina bifida without hydrocephalus	0.003	0.997	0.000
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.003	0.997	0.000
E78.2 Mixed hyperlipidaemia	0.003	0.997	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.997	0.003
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.997	0.003
H65.3 Chronic mucoid otitis media	0.003	0.997	0.000
K50.8 Other Crohn's disease	0.003	0.997	0.000
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.003	0.997	0.000
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.003	0.997	0.000
S92.40 Fracture of great toe (closed)	0.000	0.997	0.003
K59.3 Megacolon, not elsewhere classified	0.003	0.997	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.003	0.997	0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.003	0.997	0.000
O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
Q05.4 Unspecified spina bifida with hydrocephalus	0.003	0.997	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.000	0.997	0.003
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.003	0.997	0.000
Q05.8 Sacral spina bifida without hydrocephalus	0.003	0.997	0.000
Q05.6 Thoracic spina bifida without hydrocephalus	0.003	0.997	0.000
Q05.5 Cervical spina bifida without hydrocephalus	0.003	0.997	0.000
Q05.3 Sacral spina bifida with hydrocephalus	0.003	0.997	0.000
Q05.2 Lumbar spina bifida with hydrocephalus	0.003	0.997	0.000
Q05.1 Thoracic spina bifida with hydrocephalus	0.003	0.997	0.000
Q05.0 Cervical spina bifida with hydrocephalus	0.003	0.997	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.003	0.997	0.000
S92.70 Multiple fractures of foot (closed)	0.000	0.997	0.003
S92.3 Fracture of metatarsal bone	0.000	0.997	0.003
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
Y44.2 Anticoagulants	0.000	0.997	0.003
O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O98.7 Human immunodeficiency [HIV] disease complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O98.1 Syphilis complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
S92.4 Fracture of great toe	0.000	0.997	0.003
O96.9 Death from unspecified obstetric cause	0.003	0.997	0.000
O96.1 Death from indirect obstetric cause	0.003	0.997	0.000
O96.0 Death from direct obstetric cause	0.003	0.997	0.000
O97.9 Death from sequelae of obstetric cause, unspecified	0.003	0.997	0.000
O97.1 Death from sequelae of indirect obstetric cause	0.003	0.997	0.000
O97.0 Death from sequelae of direct obstetric cause	0.003	0.997	0.000
J36 Peritonsillar abscess	0.003	0.997	0.000
O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.003	0.997	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
N25.8 Other disorders resulting from impaired renal tubular function	0.003	0.997	0.000
O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
S92.7 Multiple fractures of foot	0.000	0.997	0.003
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.003	0.997	0.000
S92 Fracture of foot, except ankle	0.000	0.997	0.003
M79.00 Rheumatism, unspecified (Multiple sites)	0.003	0.997	0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.003	0.997	0.000
I34.1 Mitral (valve) prolapse	0.000	0.997	0.003
M21.0 Valgus deformity, not elsewhere classified	0.000	0.997	0.003
F60.9 Personality disorder, unspecified	0.000	0.997	0.003
H54.9 Unspecified visual impairment (binocular)	0.000	0.997	0.003
F60.7 Dependent personality disorder	0.000	0.997	0.002
X63.9 Unspecified place	0.000	0.997	0.002
X63.8 Other specified place	0.000	0.997	0.002
X63.7 Farm	0.000	0.997	0.002
X63.6 Industrial and construction area	0.000	0.997	0.002
X63.5 Trade and service area	0.000	0.997	0.002
X63.4 Street and highway	0.000	0.997	0.002
X63.3 Sports and athletics area	0.000	0.997	0.002
X63.2 School, other institution and public administrative area	0.000	0.997	0.002
X63.1 Residential institution	0.000	0.997	0.002
M47.99 Spondylosis, unspecified (Site unspecified)	0.002	0.998	0.000
M48.06 Spinal stenosis (Lumbar region)	0.002	0.998	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.002	0.998	0.000
D47.4 Osteomyelofibrosis	0.002	0.998	0.000
F60 Specific personality disorders	0.000	0.998	0.002
S92.31 Fracture of metatarsal bone (open)	0.000	0.998	0.002
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.002	0.998	0.000
N60.0 Solitary cyst of breast	0.002	0.998	0.000
F60.0 Paranoid personality disorder	0.000	0.998	0.002
S92.2 Fracture of other tarsal bone(s)	0.000	0.998	0.002
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
N26 Unspecified contracted kidney	0.002	0.998	0.000
S92.71 Multiple fractures of foot (open)	0.000	0.998	0.002
K75.8 Other specified inflammatory liver diseases	0.000	0.998	0.002
S92.41 Fracture of great toe (open)	0.000	0.998	0.002
M79.0 Rheumatism, unspecified	0.002	0.998	0.000
X68.9 Unspecified place	0.000	0.998	0.002
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
F60.6 Anxious [avoidant] personality disorder	0.000	0.998	0.002
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
S70.0 Contusion of hip	0.002	0.998	0.000
N25 Disorders resulting from impaired renal tubular function	0.002	0.998	0.000
K92.8 Other specified diseases of digestive system	0.002	0.998	0.000
C18.0 Caecum	0.002	0.998	0.000
M21.09 Valgus deformity, not elsewhere classified (Site unspecified)	0.000	0.998	0.002
M21.08 Valgus deformity, not elsewhere classified (Other)	0.000	0.998	0.002
M21.05 Valgus deformity, not elsewhere classified (Pelvic region and thigh)	0.000	0.998	0.002
M21.04 Valgus deformity, not elsewhere classified (Hand)	0.000	0.998	0.002
M21.03 Valgus deformity, not elsewhere classified (Forearm)	0.000	0.998	0.002
M21.02 Valgus deformity, not elsewhere classified (Upper arm)	0.000	0.998	0.002
M21.01 Valgus deformity, not elsewhere classified (Shoulder region)	0.000	0.998	0.002
M21.00 Valgus deformity, not elsewhere classified (Multiple sites)	0.000	0.998	0.002
N91 Absent, scanty and rare menstruation	0.002	0.998	0.000
S91.1 Open wound of toe(s) without damage to nail	0.000	0.998	0.002
S92.5 Fracture of other toe	0.000	0.998	0.002
T17.2 Foreign body in pharynx	0.002	0.998	0.000
M79.06 Rheumatism, unspecified (Lower leg)	0.002	0.998	0.000
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.000	0.998	0.002
D47.1 Chronic myeloproliferative disease	0.002	0.998	0.000
S92.1 Fracture of talus	0.000	0.998	0.002
M84.41 Pathological fracture, not elsewhere classified (Shoulder region)	0.002	0.998	0.000
M79.08 Rheumatism, unspecified (Other)	0.002	0.998	0.000
N64.5 Other signs and symptoms in breast	0.002	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.000	0.998	0.002
S82.80 Fractures of other parts of lower leg (closed)	0.002	0.998	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.000	0.998	0.002
L43.9 Lichen planus, unspecified	0.002	0.998	0.000
N60 Benign mammary dysplasia	0.002	0.998	0.000
F60.4 Histrionic personality disorder	0.000	0.998	0.002
F60.1 Schizoid personality disorder	0.000	0.998	0.002
S92.9 Fracture of foot, unspecified	0.000	0.998	0.002
J81 Pulmonary oedema	0.002	0.998	0.000
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
T93.1 Sequelae of fracture of femur	0.002	0.998	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.002	0.998	0.000
F60.8 Other specific personality disorders	0.000	0.998	0.002
N25.0 Renal osteodystrophy	0.002	0.998	0.000
O75.7 Vaginal delivery following previous Caesarean section	0.000	0.998	0.002
S09.9 Unspecified injury of head	0.000	0.998	0.002
N62 Hypertrophy of breast	0.002	0.998	0.000
K01.0 Embedded teeth	0.000	0.998	0.002
K75 Other inflammatory liver diseases	0.000	0.998	0.002
N91.5 Oligomenorrhoea, unspecified	0.002	0.998	0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.002	0.998	0.000
H80 Otosclerosis	0.002	0.998	0.000
F60.2 Dissocial personality disorder	0.000	0.998	0.002
M84.4 Pathological fracture, not elsewhere classified	0.002	0.998	0.000
F69 Unspecified disorder of adult personality and behaviour	0.000	0.998	0.002
S92.21 Fracture of other tarsal bone(s) (open)	0.000	0.998	0.002
T93 Sequelae of injuries of lower limb	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.000	0.998	0.002
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M79.04 Rheumatism, unspecified (Hand)	0.002	0.998	0.000
M79.03 Rheumatism, unspecified (Forearm)	0.002	0.998	0.000
M79.02 Rheumatism, unspecified (Upper arm)	0.002	0.998	0.000
M84 Disorders of continuity of bone	0.002	0.998	0.000
M84.42 Pathological fracture, not elsewhere classified (Upper arm)	0.002	0.998	0.000
N91.1 Secondary amenorrhoea	0.002	0.998	0.000
N91.0 Primary amenorrhoea	0.002	0.998	0.000
N25.1 Nephrogenic diabetes insipidus	0.002	0.998	0.000
S43.0 Dislocation of shoulder joint	0.000	0.998	0.002
N11 Chronic tubulo-interstitial nephritis	0.002	0.998	0.000
N25.9 Disorder resulting from impaired renal tubular function, unspecified	0.002	0.998	0.000
N60.9 Benign mammary dysplasia, unspecified	0.002	0.998	0.000
T93.0 Sequelae of open wound of lower limb	0.002	0.998	0.000
M84.8 Other disorders of continuity of bone	0.002	0.998	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.002	0.998	0.000
N91.4 Secondary oligomenorrhoea	0.002	0.998	0.000
N91.3 Primary oligomenorrhoea	0.002	0.998	0.000
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.000	0.998	0.002
T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified	0.002	0.998	0.000
F64.0 Transsexualism	0.000	0.998	0.002
H54.0 Blindness, both eyes	0.000	0.998	0.002
I97.2 Postmastectomy lymphoedema syndrome	0.002	0.998	0.000
L12.1 Cicatricial pemphigoid	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
F60-F69 Disorders of adult personality and behaviour	0.000	0.998	0.002
M84.87 Other disorders of continuity of bone (Ankle and foot)	0.002	0.998	0.000
K12.2 Cellulitis and abscess of mouth	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.000	0.998	0.002
F64 Gender identity disorders	0.000	0.998	0.002
S92.11 Fracture of talus (open)	0.000	0.998	0.002
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
S92.51 Fracture of other toe (open)	0.000	0.998	0.002
H35.0 Background retinopathy and retinal vascular changes	0.000	0.998	0.002
L13.0 Dermatitis herpetiformis	0.002	0.998	0.000
X68.8 Other specified place	0.000	0.998	0.002
X68.7 Farm	0.000	0.998	0.002
X68.6 Industrial and construction area	0.000	0.998	0.002
X68.5 Trade and service area	0.000	0.998	0.002
X68.4 Street and highway	0.000	0.998	0.002
X68.3 Sports and athletics area	0.000	0.998	0.002
X68.2 School, other institution and public administrative area	0.000	0.998	0.002
X68.1 Residential institution	0.000	0.998	0.002
X68.0 Home	0.000	0.998	0.002
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
H80.0 Otosclerosis involving oval window, nonobliterative	0.002	0.998	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.002	0.998	0.000
X61.4 Street and highway	0.000	0.998	0.002
L05 Pilonidal cyst	0.000	0.998	0.002
M79.01 Rheumatism, unspecified (Shoulder region)	0.002	0.998	0.000
S92.50 Fracture of other toe (closed)	0.000	0.998	0.002
S92.91 Fracture of foot, unspecified (open)	0.000	0.998	0.001
M84.2 Delayed union of fracture	0.002	0.998	0.000
Q00-Q07 Congenital malformations of the nervous system	0.002	0.998	0.000
F60.5 Anankastic personality disorder	0.000	0.998	0.001
Q76.0 Spina bifida occulta	0.002	0.998	0.000
H54.2 Low vision, both eyes	0.000	0.998	0.002
H80.8 Other otosclerosis	0.002	0.998	0.000
K75.2 Nonspecific reactive hepatitis	0.000	0.998	0.002
K75.1 Phlebitis of portal vein	0.000	0.998	0.002
T90.5 Sequelae of intracranial injury	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.000	0.998	0.002
M84.49 Pathological fracture, not elsewhere classified (Site unspecified)	0.001	0.998	0.000
M84.47 Pathological fracture, not elsewhere classified (Ankle and foot)	0.001	0.998	0.000
M84.46 Pathological fracture, not elsewhere classified (Lower leg)	0.001	0.998	0.000
M84.44 Pathological fracture, not elsewhere classified (Hand)	0.001	0.998	0.000
M84.43 Pathological fracture, not elsewhere classified (Forearm)	0.001	0.998	0.000
M84.40 Pathological fracture, not elsewhere classified (Multiple sites)	0.001	0.998	0.000
H80.2 Cochlear otosclerosis	0.002	0.998	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.002	0.998	0.000
N60.8 Other benign mammary dysplasias	0.002	0.998	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.002	0.998	0.000
L12 Pemphigoid	0.002	0.998	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.002	0.998	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.002	0.998	0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.002	0.998	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.000	0.998	0.002
S92.10 Fracture of talus (closed)	0.000	0.998	0.001
N11.1 Chronic obstructive pyelonephritis	0.002	0.998	0.000
Q04 Other congenital malformations of brain	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.000	0.998	0.001
X81 Intentional self-harm by jumping or lying before moving object	0.000	0.998	0.001
X80 Intentional self-harm by jumping from a high place	0.000	0.998	0.001
X79 Intentional self-harm by blunt object	0.000	0.998	0.001
X77 Intentional self-harm by steam, hot vapours and hot objects	0.000	0.998	0.001
X76 Intentional self-harm by smoke, fire and flames	0.000	0.998	0.001
X75 Intentional self-harm by explosive material	0.000	0.998	0.001
X74 Intentional self-harm by other and unspecified firearm discharge	0.000	0.998	0.001
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.000	0.998	0.001
X72 Intentional self-harm by handgun discharge	0.000	0.998	0.001
X71 Intentional self-harm by drowning and submersion	0.000	0.998	0.001
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.000	0.998	0.002
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.000	0.998	0.001
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.001
M84.25 Delayed union of fracture (Pelvic region and thigh)	0.001	0.998	0.000
L12.9 Pemphigoid, unspecified	0.002	0.998	0.000
M84.9 Disorder of continuity of bone, unspecified	0.001	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.000	0.998	0.002
N11.8 Other chronic tubulo-interstitial nephritis	0.001	0.998	0.000
X70.2 School, other institution and public administrative area	0.000	0.998	0.001
F68 Other disorders of adult personality and behaviour	0.000	0.998	0.001
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
D09.0 Bladder	0.000	0.998	0.002
Q60.0 Renal agenesis, unilateral	0.000	0.998	0.002
X69.0 Home	0.000	0.998	0.001
X83 Intentional self-harm by other specified means	0.000	0.998	0.001
M84.45 Pathological fracture, not elsewhere classified (Pelvic region and thigh)	0.001	0.998	0.000
M84.89 Other disorders of continuity of bone (Site unspecified)	0.001	0.998	0.000
M84.88 Other disorders of continuity of bone (Other)	0.001	0.998	0.000
M84.86 Other disorders of continuity of bone (Lower leg)	0.001	0.998	0.000
M84.85 Other disorders of continuity of bone (Pelvic region and thigh)	0.001	0.998	0.000
M84.84 Other disorders of continuity of bone (Hand)	0.001	0.998	0.000
M84.82 Other disorders of continuity of bone (Upper arm)	0.001	0.998	0.000
M84.81 Other disorders of continuity of bone (Shoulder region)	0.001	0.998	0.000
M84.80 Other disorders of continuity of bone (Multiple sites)	0.001	0.998	0.000
S92.90 Fracture of foot, unspecified (closed)	0.000	0.998	0.001
X61.2 School, other institution and public administrative area	0.000	0.998	0.001
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.001	0.998	0.000
L12.0 Bullous pemphigoid	0.001	0.998	0.000
S92.0 Fracture of calcaneus	0.000	0.998	0.001
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.002	0.998	0.000
X61.9 Unspecified place	0.000	0.998	0.001
X61.8 Other specified place	0.000	0.998	0.001
X61.0 Home	0.000	0.998	0.001
X61.7 Farm	0.000	0.998	0.001
X61.6 Industrial and construction area	0.000	0.998	0.001
X61.5 Trade and service area	0.000	0.998	0.001
X61.3 Sports and athletics area	0.000	0.998	0.001
X61.1 Residential institution	0.000	0.998	0.001
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.000	0.998	0.001
F65 Disorders of sexual preference	0.000	0.998	0.001
F63 Habit and impulse disorders	0.000	0.998	0.001
Q06 Other congenital malformations of spinal cord	0.001	0.998	0.000
M84.83 Other disorders of continuity of bone (Forearm)	0.001	0.998	0.000
D21.2 Connective and other soft tissue of lower limb, including hip	0.002	0.998	0.000
F64.9 Gender identity disorder, unspecified	0.000	0.998	0.001
F64.8 Other gender identity disorders	0.000	0.998	0.001
F64.2 Gender identity disorder of childhood	0.000	0.998	0.001
F64.1 Dual-role transvestism	0.000	0.998	0.001
Q76.4 Other congenital malformations of spine, not associated with scoliosis	0.001	0.998	0.000
F61 Mixed and other personality disorders	0.000	0.998	0.001
H54 Blindness and low vision	0.000	0.998	0.002
L08 Other local infections of skin and subcutaneous tissue	0.000	0.998	0.002
D75.9 Disease of blood and blood-forming organs, unspecified	0.000	0.998	0.002
E04.1 Non-toxic single thyroid nodule	0.002	0.998	0.000
X60.9 Unspecified place	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations